↓ Skip to main content

Atorvastatin Restores PPARα Inhibition of Lipid Metabolism Disorders by Downregulating miR-21 Expression to Improve Mitochondrial Function and Alleviate Diabetic Nephropathy Progression

Overview of attention for article published in Frontiers in Pharmacology, February 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Atorvastatin Restores PPARα Inhibition of Lipid Metabolism Disorders by Downregulating miR-21 Expression to Improve Mitochondrial Function and Alleviate Diabetic Nephropathy Progression
Published in
Frontiers in Pharmacology, February 2022
DOI 10.3389/fphar.2022.819787
Pubmed ID
Authors

Jiayi Xiang, Huifang Zhang, Xingcheng Zhou, Dan Wang, Rongyu Chen, Wanlin Tan, Luqun Liang, Mingjun Shi, Fan Zhang, Ying Xiao, Yuxia Zhou, Yuanyuan Wang, Bing Guo

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 18%
Unspecified 2 12%
Student > Postgraduate 2 12%
Librarian 1 6%
Student > Bachelor 1 6%
Other 3 18%
Unknown 5 29%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 24%
Medicine and Dentistry 3 18%
Unspecified 2 12%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Immunology and Microbiology 1 6%
Other 1 6%
Unknown 5 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2022.
All research outputs
#20,650,458
of 26,237,895 outputs
Outputs from Frontiers in Pharmacology
#8,730
of 20,178 outputs
Outputs of similar age
#389,478
of 541,204 outputs
Outputs of similar age from Frontiers in Pharmacology
#516
of 1,262 outputs
Altmetric has tracked 26,237,895 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,178 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 541,204 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,262 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.